Clinical guidelines from Taiwanese medical societies highlight recommendations for blood pressure, cholesterol, and sugar control to reduce recurrent cardiovascular events in patients with ASCVD.
Provides a performance guide highlighting recommendations for blood pressure, cholesterol, and sugar control to improve clinical outcomes in patients with ASCVD in Taiwan.
Atherosclerotic cardiovascular disease (ASCVD), including coronary artery disease, cerebrovascular disease, and peripheral artery disease, carries a high morbidity and mortality. Risk factor control is especially important for patients with ASCVD to reduce recurrent cardiovascular events. Clinical guidelines have been developed by the Taiwan Society of Cardiology, Taiwan Society of Lipids and Atherosclerosis, and Diabetes Association of Republic of China (Taiwan) to assist health care professionals in Taiwan about the control of hypertension, hypercholesterolemia and diabetes mellitus. This article is to highlight the recommendations about blood pressure, cholesterol, and sugar control for ASCVD. Some medications that are beneficial for ASCVD were also reviewed. We hope the clinical outcomes of ASCVD can be improved in Taiwan through the implementation of these recommendations.
Li et al. (Sat,) conducted a review in Atherosclerotic cardiovascular disease (ASCVD). Risk factor control (blood pressure, cholesterol, and sugar) was evaluated. Clinical guidelines from Taiwanese medical societies highlight recommendations for blood pressure, cholesterol, and sugar control to reduce recurrent cardiovascular events in patients with ASCVD.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: